Fasikl Receives FDA Clearance for Felix™ NeuroAI™ Wristband, the First and Only AI-Powered Treatment for Essential Tremor

Powered by recent breakthroughs in AI technologies, Felix offers a noninvasive, drug-free alternative to surgery and medications, providing all-day relief for adults living with essential tremor

(MINNEAPOLIS, BUSINESS WIRE) – Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the first-of-its-kind Felix™ NeuroAI™ Wristband for tremor-related functional limitations in the upper limbs in adults with essential tremor.